Clarifying the effect of gut microbiota on allergic conjunctivitis risk is instrumental for predictive, preventive, and personalized medicine: a Mendelian randomization analysis

Abstract

Background Allergic conjunctivitis is an ocular immune disease which affects the conjunctiva, eyelids, and cornea. Growing evidence implicates the gut microbiota in balancing and modulating immunity response, and in the pathogenesis of allergic disease. As a result, gut microbial imbalance could be a useful indicator for allergic conjunctivitis. From the perspective of predictive, preventive, and personalized medicine (PPPM), clarifying the role of gut microbial imbalance in the development of allergic conjunctivitis could provide a window of opportunity for primary prediction, targeted prevention, and personalized treatment of the disease. Working hypothesis and methodology In our study, we hypothesized that individuals with microbial dysbiosis may be more susceptible to allergic conjunctivitis due to an increased inflammatory response. To verify the working hypothesis, our analysis selected genetic variants linked with gut microbiota features ( N = 18,340) and allergic conjunctivitis (4513 cases, 649,376 controls) from genome-wide association studies. The inverse-variance weighted (IVW) estimate, Mendelian randomization (MR)-Egger, weighted median estimator, maximum likelihood estimator (MLE), and MR robust adjusted profile score (MR.RAPS) were employed to analyze the impact of gut microbiota on the risk of allergic conjunctivitis and identify allergic conjunctivitis-related gut microbes. Ultimately, these findings may enable the identification of individuals at risk of allergic conjunctivitis through screening of gut microbial imbalances, and allow for new targeted prevention and personalized treatment strategies. Results Genetic liability to Ruminococcaceae_UCG_002 (OR, 0.83; 95% CI, 0.70–0.99; P = 4.04×10 −2 ), Holdemanella (OR, 0.78; 95% CI, 0.64–0.96; P = 2.04×10 −2 ), Catenibacterium (OR, 0.69; 95% CI, 0.56–0.86; P = 1.09×10 −3 ), Senegalimassilia (OR, 0.71; 95% CI, 0.55–0.93; P = 1.23×10 −2 ) genus were associated with a low risk of allergic conjunctivitis with IVW. Besides, we found suggestive associations of a genetic-driven increase in the Oscillospira (OR, 1.41; 95% CI, 1.00–2.00; P = 4.63×10 −2 ) genus with a higher risk of allergic conjunctivitis. Moreover, MLE and MR.RAPS show consistent results with IVW after further validation and strengthened confidence in the true causal associations. No heterogeneity and pleiotropy was detected. Conclusions Our study suggests that gut microbiota may play a causal role in the development of allergic conjunctivitis and provides new in...

Causal associations between gut microbiota and primary biliary cholangitis: a bidirectional two-sample Mendelian randomization study

“…Moreover, the non-reversibility of heredity in MR analysis is advantageous in addressing concerns related to reverse causation interference ( Xu Q. et al, 2022 ). Although the MR method has been employed in several studies to examine the potential causal relationship between gut microbiota and different diseases ( Li et al, 2022 ; Liu et al, 2023 ; Long et al, 2023 ), there is currently limited evidence regarding the causal association between gut microbiota and PBC.…”

Gut Microbiota Profiles in Myopes and Nonmyopes

“…This finding may be explained with the results of Liu et al who found an increased risk of allergic conjunctivitis, resulting from decreased level of Catenibacterium . 76 Children with allergic conjunctivitis have a 2.35-fold higher incidence and risk of myopia compared with children without allergic conjunctivitis. 77 Nonetheless, there is limited research on Catenibacterium in relation to the eye.…”

Genetically predicted causality between gut microbiota, blood metabolites, and intracerebral hemorrhage: a bidirectional Mendelian randomization study

“…Senegalimassilia is a genus of actinobacterial strains that are Gram-positive, anaerobic, and coccobacilli-shaped ( Han et al, 2020 ). The genus Senegalimassilia was found to be a protective factor for various diseases, including hypertension ( Li et al, 2023b ), allergic conjunctivitis ( Liu et al, 2023 ). Based on our findings, this could potentially provide a strategy for extracting this bacterium from fecal samples in the future to prevent a specific disease.…”